New hope for hemophilia b: trial shows bleeding control in chinese patients

NCT ID NCT05365217

First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 18 times

Summary

This study tested a medicine called nonacog beta pegol (N9-GP) in 30 Chinese men aged 12-70 with moderate to severe hemophilia B. The medicine is injected into a vein to treat or prevent bleeding episodes. The trial lasted about 12-16 months and checked how well the medicine stopped bleeding and its safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Children's Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100045, China

  • Children's Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310052, China

  • Fujian Medical University Union Hospital-Hematology

    Fuzhou, Fujian, 350001, China

  • Henan Cancer Hospital-Hematology

    Zhengzhou, Henan, 450003, China

  • Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology

    Tianjin, Tianjin Municipality, 300020, China

  • Jinan Central Hospital

    Jinan, Shandong, 250013, China

  • Nanfang Hospital, Southern Medical University-Haematology

    Guangzhou, Guangdong, 510515, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100730, China

  • The Affiliated Hospital of Guizhou Medical University-Hematology

    Guiyang, Guizhou, 550004, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266000, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266555, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215006, China

  • The Second Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, 650101, China

  • Tongji Hospital, Tongji Medical College of HUST-Hematology

    Wuhan, Hubei, 430030, China

  • Xiangya Hospital Central-South University

    Changsha, Hunan, 410008, China

Conditions

Explore the condition pages connected to this study.